Literature DB >> 773493

Bran tablets and diverticular disease.

I Taylor, H L Duthie.   

Abstract

Three treatments for patients with symptomatic diverticular disease were compared in a crossover trial. Neither a high-roughage diet (HRD) nor Normacol plus an antispasmodic were as effective as bran tablets, which produced a significant increase in daily stool weight and a decrease in the intestinal transit time. An abnormal rapid electrical rhythm in colonic smooth muscle was found initially in 80% of the patients, but the incidence was reduced by each treatment after one month; it was present in only 40% of patients after treatment with bran tablets. Only bran significantly reduced a high percentage motility to within normal limits. Bran proved to be the most effective treatment, not only in improving the symptoms in patients with diverticular disease but also in returning to normal the abnormal pathophysiological changes. Bran tablets were both convenient and acceptable as well as effective.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 773493      PMCID: PMC1639633          DOI: 10.1136/bmj.1.6016.988

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  THE INTRALUMINAL PRESSURE PATTERNS IN DIVERTICULOSIS OF THE COLON. I. RESTING PATTERNS OF PRESSURE. II. THE EFFECT OF MORPHINE.

Authors:  N S PAINTER; S C TRUELOVE
Journal:  Gut       Date:  1964-06       Impact factor: 23.059

2.  Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease.

Authors:  D P Burkitt; A R Walker; N S Painter
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

3.  Transit times of food in patients with diverticulosis or irritable colon syndrome and normal subjects.

Authors:  O N Manousos; S C Truelove; K Lumsden
Journal:  Br Med J       Date:  1967-09-23

4.  A ne method for studying gut transit times using radioopaque markers.

Authors:  J M Hinton; J E Lennard-Jones; A C Young
Journal:  Gut       Date:  1969-10       Impact factor: 23.059

5.  Postmortem survey of diverticular disease of the colon. I. Diverticulosis and diverticulitis.

Authors:  L E Hughes
Journal:  Gut       Date:  1969-05       Impact factor: 23.059

6.  Unprocessed bran in treatment of diverticular disease of the colon.

Authors:  N S Painter; A Z Almeida; K W Colebourne
Journal:  Br Med J       Date:  1972-04-15
  6 in total
  25 in total

Review 1.  Physiology and pathophysiology of colonic motor activity (2).

Authors:  S K Sarna
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Effect of fibre from bran cereal on gastroenteropancreatic hormone responses of normal adults.

Authors:  A M Connell; A M McCarroll; M H Chen
Journal:  Ir J Med Sci       Date:  1980-02       Impact factor: 1.568

3.  Clinical rheumatology has advanced.

Authors:  A S Dixon
Journal:  Br Med J       Date:  1977-04-16

4.  Epidemiology and pathophysiology of diverticular disease.

Authors:  Marc R Matrana; David A Margolin
Journal:  Clin Colon Rectal Surg       Date:  2009-08

5.  The medical and nonoperative treatment of diverticulitis.

Authors:  Heath Beckham; Charles B Whitlow
Journal:  Clin Colon Rectal Surg       Date:  2009-08

6.  Etiology and pathophysiology of diverticular disease.

Authors:  Kristina G Hobson; Patricia L Roberts
Journal:  Clin Colon Rectal Surg       Date:  2004-08

7.  Is there a myoelectrical abnormality in the irritable colon syndrome?

Authors:  I Taylor; C Darby; P Hammond; P Basu
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

8.  Effect of secoverine on colonic myoelectric activity in diverticular disease of the colon.

Authors:  M Suchowiecky; D D Clarke; M Bhasker; R J Perry; W J Snape
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

Review 9.  Diverticular disease. Epidemiology and pharmacological treatment.

Authors:  L J Cheskin; R D Lamport
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

10.  Effects of bran on serum cholesterol, faecal mass, fat, bile acids and neutral sterols, and biliary lipids in patients with diverticular disease of the colon.

Authors:  S Tarpila; T A Miettinen; L Metsäranta
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.